Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Study pinpoints how gut microbes boost the body's response to cancer immunotherapy

Cancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patients get the same benefit from these powerful therapies.

4 May 2023

Eli Lilly trial reveals Alzheimer's drug that significantly slows cognitive decline

Study examined the safety and efficacy of the study drug donanemab in participants with early Alzheimer's disease (AD).

4 May 2023

The Human Protein Atlas and Precision Medicine

In this interview, Mathias Uhlen, the Director of the Human Protein Atlas, talks to NewsMed about the Human Protein Atlas and Precision Medicine.

From MGI 4 May 2023

Study suggests SARS-CoV-2 vaccination in pregnancy induces diverging maternal and infant cord antibody functions

Researchers explored the differences in infant and maternal cord antibody functions between SARS-CoV-2 infection and vaccination during pregnancy.

4 May 2023

Advancing the development of vaccines through recombinant technology

In this interview, News-Medical talks to Dr. Amy Sheng, the head of CRO at Sino Biological, about current developments in the field of vaccine development through recombinant techniques.

From Sino Biological Inc. 4 May 2023

COVID-19 risk: natural immunity vs. vaccine induced immunity

Researchers evaluated the immune protection conferred by previous SARS-CoV-2 infection and/or COVID-19 vaccines.

4 May 2023

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, today announced the introduction of Gyrolab® Generic Cyno Anti-Drug Antibodies (ADA) Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.

From Gyros Protein Technologies AB 4 May 2023

Revving up COVID mRNA vaccines: Algorithm generates 128-fold increase in antibodies

Research paper proposes a new method for predicting highly expressed genes based on codon usage bias and minimum free energy of mRNA secondary structures. The method involves constructing a stochastic grammar that generates sequences with high CAI and low MFE, and testing it on two mRNA vaccines.

3 May 2023

Genomic study helps develop mRNA vaccine candidate against dengue virus

Researchers in India say that data from a detailed genomic study of the dengue virus has helped them develop an mRNA (messenger RNA) vaccine candidate capable of neutralizing all four strains of the pathogen.

3 May 2023

Cats and COVID-19: measuring seroprevalence against SARS-CoV-2 in domestic cats

Researchers tested the seroprevalence against SARS-CoV-2 in pet cats in the U.K.

2 May 2023

Study identifies immune signature to predict severe COVID-19 in cardiovascular patients

Research investigates whether the severity of SARS-CoV-2 infection can be predicted by analyzing the immunophenotype in the blood of cardiovascular disease (CVD) patients.

1 May 2023

A high proportion of adults in Europe do not have protective antibody concentrations against diphtheria

Researchers conducted a retrospective analysis of seroprotection against tetanus and diphtheria among residents in Austria.

1 May 2023

Reducing COVID-19 burden: could Bacille Calmette-Guérin (BCG) vaccines confer protection?

Researchers investigated whether BCG vaccines could lower COVID-19 burden.

1 May 2023

Urgent call for improved diagnostics, treatments, and vaccines against deadly Hantavirus

Scientists discuss hantavirus infections, which are a type of viral hemorrhagic fever that can be transmitted to humans through exposure to infected rodents in endemic areas.

30 Apr 2023

NVX-CoV2373 COVID vaccine safe and effective in preventing COVID-19 in adolescent

Research reports the results of a phase 3 clinical trial evaluating the safety, immunogenicity, and efficacy of the NVX-CoV2373 vaccine in adolescents aged 12 to 17 years. The study found that the vaccine was safe, immunogenic, and efficacious in preventing COVID-19, including the Delta variant, in adolescents.

27 Apr 2023

Antibody News and Research

Further Reading

Study pinpoints how gut microbes boost the body's response to cancer immunotherapy

Eli Lilly trial reveals Alzheimer's drug that significantly slows cognitive decline

The Human Protein Atlas and Precision Medicine

Study suggests SARS-CoV-2 vaccination in pregnancy induces diverging maternal and infant cord antibody functions

Advancing the development of vaccines through recombinant technology

COVID-19 risk: natural immunity vs. vaccine induced immunity

Gyros Protein Technologies introduces Gyrolab Generic Cyno ADA Kit Reagents to support pre-clinical immunogenicity assessment

Revving up COVID mRNA vaccines: Algorithm generates 128-fold increase in antibodies

Genomic study helps develop mRNA vaccine candidate against dengue virus

Cats and COVID-19: measuring seroprevalence against SARS-CoV-2 in domestic cats

Study identifies immune signature to predict severe COVID-19 in cardiovascular patients

A high proportion of adults in Europe do not have protective antibody concentrations against diphtheria

Reducing COVID-19 burden: could Bacille Calmette-Guérin (BCG) vaccines confer protection?

Urgent call for improved diagnostics, treatments, and vaccines against deadly Hantavirus

NVX-CoV2373 COVID vaccine safe and effective in preventing COVID-19 in adolescent

Molnupiravir treatment reduces risk of long COVID in high risk patients

Unique treatment can eradicate pancreatic tumors while stopping cancer progression

Research identifies Th1 memory CD4+ T cells as key to protect against emerging poxvirus skin infections

What is the risk for symptomatic H5N1 virus infection in humans?

Neurological phenotypes induced by SARS-CoV-2 spike protein in neurons

Using single B cell screening to boost antibody discovery eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo